Montag A & Associates Inc Veracyte, Inc. Transaction History
Montag A & Associates Inc
- $2.09 Billion
- Q3 2024
A detailed history of Montag A & Associates Inc transactions in Veracyte, Inc. stock. As of the latest transaction made, Montag A & Associates Inc holds 32 shares of VCYT stock, worth $1,264. This represents 0.0% of its overall portfolio holdings.
Number of Shares
32
Previous 32
-0.0%
Holding current value
$1,264
Previous $0
Infinity%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding VCYT
# of Institutions
279Shares Held
79.9MCall Options Held
42.3KPut Options Held
18.2K-
Black Rock Inc. New York, NY7.79MShares$308 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.75MShares$306 Million0.0% of portfolio
-
Wellington Management Group LLP Boston, MA6.88MShares$272 Million0.03% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI5.02MShares$199 Million0.27% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl4.92MShares$195 Million1.59% of portfolio
About VERACYTE, INC.
- Ticker VCYT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 71,575,904
- Market Cap $2.83B
- Description
- Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...